246 related articles for article (PubMed ID: 8396820)
1. Molecular approaches to inhibit HIV-1 tat expression and functions.
Grossi MP; Caputo A; Zucchini S; Bozzini R; Marconi PC; Manservigi R; Barbanti-Brodano G; Balboni PG
Year Immunol; 1993; 7():199-204. PubMed ID: 8396820
[No Abstract] [Full Text] [Related]
2. Trans-dominant Tat mutants with alterations in the basic domain inhibit HIV-1 gene expression.
Modesti N; Garcia J; Debouck C; Peterlin M; Gaynor R
New Biol; 1991 Aug; 3(8):759-68. PubMed ID: 1931822
[TBL] [Abstract][Full Text] [Related]
3. RNA recognition and regulation of HIV-1 gene expression by viral factor Tat.
Naryshkin NA; Gait MJ; Ivanovskaya MG
Biochemistry (Mosc); 1998 May; 63(5):489-503. PubMed ID: 9632883
[TBL] [Abstract][Full Text] [Related]
4. The tat gene and protein of the human immunodeficiency virus type 1.
Caputo A; Grossi MP; Rossi C; Campioni D; Balboni PG; Corallini A; Barbanti-Brodano G
New Microbiol; 1995 Jan; 18(1):87-110. PubMed ID: 7760763
[No Abstract] [Full Text] [Related]
5. New human gene encoding a positive modulator of HIV Tat-mediated transactivation.
Shibuya H; Irie K; Ninomiya-Tsuji J; Goebl M; Taniguchi T; Matsumoto K
Nature; 1992 Jun; 357(6380):700-2. PubMed ID: 1377363
[TBL] [Abstract][Full Text] [Related]
6. Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector.
Peng H; Callison D; Li P; Burrell C
Virology; 1996 Jun; 220(2):377-89. PubMed ID: 8661389
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
8. Block of Tat-mediated transactivation of tumor necrosis factor beta gene expression by polymeric-TAR decoys.
Brother MB; Chang HK; Lisziewicz J; Su D; Murty LC; Ensoli B
Virology; 1996 Aug; 222(1):252-6. PubMed ID: 8806505
[TBL] [Abstract][Full Text] [Related]
9. The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain.
Rappaport J; Lee SJ; Khalili K; Wong-Staal F
New Biol; 1989 Oct; 1(1):101-10. PubMed ID: 2562188
[TBL] [Abstract][Full Text] [Related]
10. Probing the proximity of the core domain of an HIV-1 Tat fragment in a Tat-TAR complex by affinity cleaving.
Huq I; Rana TM
Biochemistry; 1997 Oct; 36(41):12592-9. PubMed ID: 9376365
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of HIV-1 by a double transdominant fusion gene.
Aguilar-Cordova E; Chinen J; Donehower LA; Harper JW; Rice AP; Butel JS; Belmont JW
Gene Ther; 1995 May; 2(3):181-6. PubMed ID: 7614248
[TBL] [Abstract][Full Text] [Related]
12. Controlling human immunodeficiency virus type 1 gene expression by unnatural peptides.
Huq I; Ping YH; Tamilarasu N; Rana TM
Biochemistry; 1999 Apr; 38(16):5172-7. PubMed ID: 10213623
[TBL] [Abstract][Full Text] [Related]
13. Antitat gene therapy: a candidate for late-stage AIDS patients.
Lisziewicz J; Sun D; Lisziewicz A; Gallo RC
Gene Ther; 1995 May; 2(3):218-22. PubMed ID: 7614253
[TBL] [Abstract][Full Text] [Related]
14. Influence of the small leader exons 2 and 3 on human immunodeficiency virus type 1 gene expression.
Krummheuer J; Lenz C; Kammler S; Scheid A; Schaal H
Virology; 2001 Aug; 286(2):276-89. PubMed ID: 11485396
[TBL] [Abstract][Full Text] [Related]
15. Tat is required for efficient HIV-1 reverse transcription.
Harrich D; Ulich C; García-Martínez LF; Gaynor RB
EMBO J; 1997 Mar; 16(6):1224-35. PubMed ID: 9135139
[TBL] [Abstract][Full Text] [Related]
16. Block of HIV-1 infection by a combination of antisense tat RNA and TAR decoys: a strategy for control of HIV-1.
Chang HK; Gendelman R; Lisziewicz J; Gallo RC; Ensoli B
Gene Ther; 1994 May; 1(3):208-16. PubMed ID: 7584083
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
Kashanchi F; Sadaie MR; Brady JN
Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
[TBL] [Abstract][Full Text] [Related]
18. Ribozyme targeting of HIV-1 LTR.
Ventura M; Wang P; Franck N; Saragosti S
Biochem Biophys Res Commun; 1994 Sep; 203(2):889-98. PubMed ID: 8093072
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures.
Rounseville MP; Lin HC; Agbottah E; Shukla RR; Rabson AB; Kumar A
Virology; 1996 Feb; 216(2):411-7. PubMed ID: 8607271
[TBL] [Abstract][Full Text] [Related]
20. Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator.
Marcello A; Zoppé M; Giacca M
IUBMB Life; 2001 Mar; 51(3):175-81. PubMed ID: 11547919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
